James Andry, MD
Sleep Medicine · San Antonio, TXNPI 1316010986
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (60.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 60.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $50,655 and has fallen 68.0% since, to $16,218 in 2025. Among sleep medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $445.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$61K
- Harmony Biosciences LLC$17K
- Eli Lilly$13K
- Lilly USA, LLC$5K
- Amgen$2K
- Eisai Inc.$886
- plus $2K from 8 others
Across 902 payments — averaging $2297.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$829K
- Takeda Pharmaceuticals U.S.A., Inc.$489K
- Eli Lilly$400K
- Alkermes, Inc.$317K
- Amgen$25K
- Vanda Pharmaceuticals Inc.$7K
- plus $5K from 1 others
What the payments were for
- Consulting fees$11,15311%
- Speaking & faculty fees$59,85960%
- Travel & lodging$12,54913%
- Food & beverage$16,13316%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 97 | $60,573 |
| Harmony Biosciences LLC | 33 | $16,899 |
| Eli Lilly | 21 | $12,991 |
| Lilly USA, LLC | 10 | $4,656 |
| Amgen | 3 | $1,674 |
| Eisai Inc. | 9 | $886 |
| Inspire Medical Systems, Inc. | 31 | $875 |
| Axsome Therapeutics, Inc. | 6 | $401 |
| Avadel Specialty Pharmaceuticals, LLC | 2 | $225 |
| ZOLL Respicardia, Inc. | 3 | $169 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $167 |
| 3b Medical, Inc. | 2 | $120 |
| Idorsia Pharmaceuticals US Inc | 1 | $101 |
| Fisher & Paykel Healthcare Inc | 2 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$99,779 in reported general payments places this provider in the 95th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sleep medicine in San Antonio
- Karen Hentschel FranksSan Antonio$18K
- Hanul BhandariSan Antonio$10K
- Nici BothwellSan Antonio$3K
- Avie GrunspanSan Antonio$3K
- Rafael SantiagoSan Antonio$3K
- Sreejith PillaiSan Antonio$2K
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.